Single Ascending Dose Study With BPL-003 in Healthy Subjects

A Two-part Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of Intranasal BPL-003 (5-Methoxy-N,N-dimethyltryptamine Benzoate) in Healthy Subjects

The study will evaluate safety, tolerability and PK profile of BPL-003 in healthy subjects

Inclusion Criteria:

• Medically healthy based on medical records and study specific assessments

Exclusion Criteria:

• Presence or history of severe adverse reaction to any drug or drug excipient